These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9030377)

  • 1. Topical foscarnet for aciclovir-resistant mucocutaneous herpes infections in AIDS.
    Smith NA; Wood C; Asboe D; Bingham JS
    AIDS; 1997 Feb; 11(2):254-5. PubMed ID: 9030377
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections.
    Safrin S
    Adv Exp Med Biol; 1996; 394():59-66. PubMed ID: 8815710
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

  • 4. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
    Morfin F; Frobert E; Thouvenot D
    Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
    Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
    Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foscarnet for herpes.
    Posit Aware; 1995; ():5. PubMed ID: 11362667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.
    Lascaux AS; Caumes E; Deback C; Melica G; Challine D; Agut H; Lévy Y
    J Med Virol; 2012 Feb; 84(2):194-7. PubMed ID: 22170537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous foscarnet in the management of acyclovir-resistant herpes simplex virus type 2 in acute retinal necrosis in children.
    Khurana RN; Charonis A; Samuel MA; Gupta A; Tawansy KA
    Med Sci Monit; 2005 Dec; 11(12):CS75-8. PubMed ID: 16319793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C; Bianchi A
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foscarnet effective in acyclovir-resistant herpes.
    Am Pharm; 1991 Nov; NS31(11):12. PubMed ID: 1836936
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
    Verdonck LF; Cornelissen JJ; Smit J; Lepoutre J; de Gast GC; Dekker AW; Rozenberg-Arska M
    Bone Marrow Transplant; 1993 Feb; 11(2):177-9. PubMed ID: 8382096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acyclovir-resistant herpes exulcerans et persistens. Type II].
    Klammer M; Kuhn A; Ruzicka T; Stege H
    Hautarzt; 2003 Apr; 54(4):362-4. PubMed ID: 12669211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
    Balfour HH; Benson C; Braun J; Cassens B; Erice A; Friedman-Kien A; Klein T; Polsky B; Safrin S
    J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):254-60. PubMed ID: 8106965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful foscarnet therapy for mucocutaneous infection with herpes simplex virus in a recipient after unrelated bone marrow transplantation.
    Iino T; Gondo H; Ohno Y; Minagawa H; Iwasaki H; Maruyama T; Nakashima H; Niho Y
    Bone Marrow Transplant; 1996 Dec; 18(6):1185-8. PubMed ID: 8971394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature.
    Hatchette T; Tipples GA; Peters G; Alsuwaidi A; Zhou J; Mailman TL
    Pediatr Infect Dis J; 2008 Jan; 27(1):75-7. PubMed ID: 18162946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
    Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive oral herpes simplex virus type 1 infection in a haematopoietic stem cell transplant recipient not responding to aciclovir.
    Moses SE; Osborne W; Valappil M; Collin M; Lee D; Waugh S; Jackson G; Parry CM; Crowley B
    J Clin Virol; 2011 Oct; 52(2):67-9. PubMed ID: 21665532
    [No Abstract]   [Full Text] [Related]  

  • 19. Foscavir receives new indication.
    AIDS Alert; 1997 Jun; 12(6):71. PubMed ID: 11364364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of mucocutaneous herpes simplex virus infections unresponsive to acyclovir with topical foscarnet cream in AIDS patients: a phase I/II study.
    Javaly K; Wohlfeiler M; Kalayjian R; Klein T; Bryson Y; Grafford K; Martin-Munley S; Hardy WD
    J Acquir Immune Defic Syndr; 1999 Aug; 21(4):301-6. PubMed ID: 10428108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.